Felipe A. Montellano is a researcher at the Institute of Clinical Epidemiology and Biometry at the University of Würzburg, Germany, specializing in epidemiology with a focus on stroke genetics, ischemic stroke, and cardiovascular health. His research advances understanding of the genetic factors in stroke for drug discovery and risk assessment, with an emphasis on diverse ancestries. Dr. Montellano has contributed to studies on platelet markers in ischemic stroke, blood-based biomarkers for prognosis, and echocardiography's role in diagnosing cardiac dysfunction in stroke patients, as well as the cardiovascular effects of SARS-CoV-2 infection.

• Genetic factors in stroke, including drug discovery and risk prediction across ancestries.

• Blood-based biomarkers and echocardiographic diagnostics for ischemic stroke prognosis.

• Long-term cardiovascular outcomes, including post-SARS-CoV-2 infection effects on stroke patients.

• Institute of Clinical Epidemiology and Biometry, University of Würzburg, Germany

• Consciense/Neurocore